Across TCGA pan-cancer cohorts, ZNF705CP RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated ZNF705CP data layer.
The strongest signal is observed in lung adenocarcinoma (LUAD), where higher ZNF705CP RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ZNF705CP expression acts as an unfavorable survival marker, although some lineages such as BLCA show a favorable association.
LUAD, MESO, and THCA are the cancer types where ZNF705CP RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.